Laura Harris: Unfiltered

Facing a severe cash crunch, Jasper Therapeutics is exploring a sale or even a shutdown, placing the future of its promising urticaria drug, briquilimab, in limbo.

Canada Post unveils its final 'Places of Pride' stamps, honouring four historic sites that were crucial in the fight for equality and community.

Biotech firm Kimera Labs implements a unified quality system for its exosome therapies and cosmetics, raising the bar in a complex regulatory landscape.

A landmark 160MWh battery project in Romania debuts Trina's advanced integrated solution, signaling a new era for grid stability in Southeast Europe.

Ardoq's new AI-first platform reasons on live, governed data, aiming to automate routine tasks and solve the trust problem plaguing enterprise AI.

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

Anza launches Pulse, an on-demand intelligence platform aiming to replace outdated reports with live pricing and policy insights for a volatile solar market.

After a 90% value drop and dividend halt at a BDC, an activist investor calls out manager Investcorp for broken promises and excessive fees.

As CEO Mike Mazzei preps for Nareit’s REITweek, investors seek clues on BrightSpire's growth plan and dividend health in a shifting CRE market.

Author Doreszell Cohen-Bakam's new book 'OUT' critiques a broken system and calls for a new generation of leaders to save democracy from the outside.

As AI's energy thirst drives a nuclear power revival, System One hires key experts to tackle small modular reactors, plant restarts, and spent fuel.

A new analysis reveals most insured Americans can't access obesity drugs, even with coverage, due to restrictive insurance hurdles.

Dstny Group appoints a new Chief Customer Officer, signaling a strategic bet on superior customer experience to fuel its aggressive European expansion.

CIBC settles a class action over mutual fund fees. Learn if you're eligible for a payout and what this means for investor rights in Canada.

South Korea's KT SAT pivots from satellite operator to a 'Total Space Solution Provider,' integrating networks to chase sovereign security and universal access.

A new partnership between Riverchain and Micro Connect uses AI and a novel funding model to inject vital capital into Hong Kong's construction industry.

Teva's new once-monthly olanzapine injection could revolutionize schizophrenia care in Europe, offering hope for better treatment adherence and patient outcomes.

A new report reveals how crypto exchanges are ditching the 'one-size-fits-all' model for specialized strategies to survive and thrive by 2030.

With a $700M market debut and quantum-proof chips, Arm-backed QBit is set to redefine security and intelligence for the next generation of AI devices.